We measured PWS gene transcripts such as Snord116/SNORD116, SNRPN, and MAGEL2 in PWS patient-derived iPSCs, PWS patient iPSC-derived neurons, and mouse primary neurons to assess maternal activation with anti-EHMT2 RNAi and therapeutic feasibility. This evidence concerns the gene SNORD116 and Prader-Willi syndrome.